Đang chuẩn bị liên kết để tải về tài liệu:
Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: A scoping review

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

There is growing interest in the collection and use of patient-reported outcome measures (PROMs) to support clinical decision making in patients with non-small cell lung cancer (NSCLC). However, an overview of research into the prognostic value of PROMs is currently lacking. |

TÀI LIỆU LIÊN QUAN

Prognostic value of preoperative highsensitivity modifed Glasgow prognostic score in advanced colon cancer: A retrospective observational study

The prognostic value of cytokeratin and sal-like protein 4 expression in hepatocellular carcinoma and intra-hepatic cholangiocarcinoma in Taiwan

The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma

The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: A large-scale cohort study

SNRPD1 conveys prognostic value on breast cancer survival and is required for anthracycline sensitivity

Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia

Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy data from a multi-institutional study in Japan

Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy